| CPC A61B 18/1233 (2013.01) [A61B 18/1445 (2013.01); A61B 2017/00017 (2013.01); A61B 2018/00589 (2013.01); A61B 2018/0063 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00648 (2013.01); A61B 2018/00666 (2013.01); A61B 2018/00678 (2013.01); A61B 2018/00684 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00708 (2013.01); A61B 2018/0072 (2013.01); A61B 2018/00755 (2013.01); A61B 2018/00761 (2013.01); A61B 2018/00779 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00827 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/00886 (2013.01); A61B 2018/00898 (2013.01); A61B 2018/00928 (2013.01); A61B 2018/00994 (2013.01); A61B 18/1206 (2013.01); A61B 18/1442 (2013.01)] | 20 Claims |

|
1. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising:
a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to:
control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of resistance, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase.
|